Targeted Intraceptor Nanoparticle for Neovascular Macular Degeneration: Preclinical Dose Optimization and Toxicology Assessment.

about

Nanoparticle Technology: Having Impact, but Needing Further Optimization.

P2860

Q55507199-976AB14D-D6A0-416A-9A53-78F464C19A04

P2860

Targeted Intraceptor Nanoparticle for Neovascular Macular Degeneration: Preclinical Dose Optimization and Toxicology Assessment.

Item

http://www.wikidata.org/entity/Q36290649

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Targeted Intraceptor Nanoparti ...... ion and Toxicology Assessment.

@ast

Targeted Intraceptor Nanoparti ...... ion and Toxicology Assessment.

@en

type

Item

label

Targeted Intraceptor Nanoparti ...... ion and Toxicology Assessment.

@ast

Targeted Intraceptor Nanoparti ...... ion and Toxicology Assessment.

@en

prefLabel

Targeted Intraceptor Nanoparti ...... ion and Toxicology Assessment.

@ast

Targeted Intraceptor Nanoparti ...... ion and Toxicology Assessment.

@en

P1476

Targeted Intraceptor Nanoparti ...... tion and Toxicology Assessment

@en

P2093

Alya Hussain

http://www.w3.org/2001/XMLSchema#string

Arun Kumar Upadhyay

http://www.w3.org/2001/XMLSchema#string

Austin Bohner

http://www.w3.org/2001/XMLSchema#string

Balamurali K Ambati

http://www.w3.org/2001/XMLSchema#string

Bonnie Archer

http://www.w3.org/2001/XMLSchema#string

Daniel Fang

http://www.w3.org/2001/XMLSchema#string

Hironori Uehara

http://www.w3.org/2001/XMLSchema#string

Lara S Carroll

http://www.w3.org/2001/XMLSchema#string

Lyska L Emerson

http://www.w3.org/2001/XMLSchema#string

Miaoling Li

http://www.w3.org/2001/XMLSchema#string

P2860

AAV2 delivery of Flt23k intraceptors inhibits murine choroidal neovascularization

Targeted intraceptor nanoparticle therapy reduces angiogenesis and fibrosis in primate and murine macular degeneration.

The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathy

Preclinical evaluation of the novel small-molecule integrin alpha5beta1 inhibitor JSM6427 in monkey and rabbit models of choroidal neovascularization.

Development of subretinal fibrosis after anti-VEGF treatment in neovascular age-related macular degeneration.

A systematic review of the adverse events of intravitreal anti-vascular endothelial growth factor injections.

Prevalence of neutralizing antibodies against adeno-associated virus (AAV) types 2, 5, and 6 in cystic fibrosis and normal populations: Implications for gene therapy using AAV vectors.

Progress and problems with the use of viral vectors for gene therapy.

A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy.

Kilovoltage radiosurgery with gold nanoparticles for neovascular age-related macular degeneration (AMD): a Monte Carlo evaluation.

P304

1606-1615

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YMTHE.2017.01.014

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Xiaohui Zhang

P577

2017-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28236576

http://www.w3.org/2001/XMLSchema#string

P921

nanoparticle

P932

5498805

http://www.w3.org/2001/XMLSchema#string

Targeted Intraceptor Nanoparticle for Neovascular Macular Degeneration: Preclinical Dose Optimization and Toxicology Assessment.

about

P2860

P2860

Targeted Intraceptor Nanoparticle for Neovascular Macular Degeneration: Preclinical Dose Optimization and Toxicology Assessment.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932